U.S. Consumer Finance Stock News

NasdaqGS:ZM
NasdaqGS:ZMSoftware

A Look At Zoom Communications (ZM) Valuation After Sector Rally And Consecutive Earnings Beats

Zoom Communications (ZM) is back in focus after a sector wide rally spotlighted enterprise software names, just days after the company reported quarterly results that exceeded its guidance midpoint for a third straight time. See our latest analysis for Zoom Communications. Even after the sector rally and the latest earnings beat, Zoom’s share price of US$77.33 sits below its recent highs, with a 30 day share price return of 12.85% decline and a year to date share price return of 7.19%...
NYSE:TRV
NYSE:TRVInsurance

Travelers Insider Sales Contrast With Strong AI Driven Underwriting Performance

Executives at Travelers Companies (NYSE:TRV) have recently carried out significant insider share sales, drawing attention to management's trading activity. The company has reported strong operating performance supported by underwriting gains, higher investment income, and efficiencies linked to AI tools. Travelers Companies sits at a current share price of $306.64. The stock is up 21.7% over the past year, 85.7% over the past 3 years, and 117.4% over the past 5 years. For investors looking...
NYSE:LVS
NYSE:LVSHospitality

A Look At Las Vegas Sands (LVS) Valuation After Major Leadership Changes And Expansion Plans

Las Vegas Sands (LVS) has put fresh leadership at the center of its story, with Patrick Dumont now serving as chairman, chief executive officer, president, and treasurer, alongside new five year agreements for other senior executives. See our latest analysis for Las Vegas Sands. The leadership reshuffle lands at a time when the share price has eased back, with a 90 day share price return of 16.77% decline and a year to date share price return of 15.44% decline. At the same time, the 1 year...
NasdaqGM:OABI
NasdaqGM:OABILife Sciences

OmniAb (OABI) Q4 Revenue Surge To US$8.4 Million Tests Bearish Loss Concerns

OmniAb (OABI) has posted its FY 2025 numbers with Q4 revenue of US$8.4 million and a basic EPS loss of US$0.11, alongside a trailing twelve month revenue figure of US$18.7 million and a basic EPS loss of US$0.57. Over recent quarters, the company has reported quarterly revenue in a range between US$2.2 million and US$10.8 million, while basic EPS losses have ranged from US$0.11 to US$0.17, leaving margins in loss-making territory and keeping the focus on how efficiently that revenue is being...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

Is It Time To Reassess Power Integrations (POWI) After Its Recent Share Price Rebound?

If you are wondering whether Power Integrations is attractively priced right now, it helps to separate the share price story from what the underlying valuation is actually saying. The stock closed at US$47.81 most recently, after a 5.7% gain over the last 30 days, with a 28.2% return year to date, alongside an 18.3% decline over the past year and a 40.0% decline over five years. Recent attention on Power Integrations has centered on its position in the semiconductor space and how investors...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

A Look At Lam Research (LRCX) Valuation After Geopolitical And AI Export Concerns Weigh On Shares

Lam Research (LRCX) shares dropped after renewed concerns about Middle East tensions, with investors reacting to potential energy price shocks, higher liquefied natural gas costs in South Korea, and possible new AI chip export rules. See our latest analysis for Lam Research. The recent 3.7% one day share price drop to US$214.68 and 10.2% 7 day share price decline come after months of strong momentum, with a 35.3% 90 day share price return and very large multi year total shareholder returns...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Is NEJM Zorevunersen Data And Phase 3 EMPEROR Plans Altering The Investment Case For Stoke Therapeutics (STOK)?

In late February 2026, Stoke Therapeutics and Biogen reported in The New England Journal of Medicine that their investigational Dravet syndrome therapy zorevunersen produced substantial, durable reductions in seizures and multi‑year cognitive and behavioral benefits, while Stoke also outlined a Phase 3 EMPEROR timeline and plans for a rolling FDA submission. These clinical and regulatory updates suggest zorevunersen could shift treatment expectations in Dravet syndrome and intensify focus on...
NYSE:DRI
NYSE:DRIHospitality

Will Margin-Focused Pricing and Promotions Change Darden Restaurants' (DRI) Resilient Income Narrative?

Darden Restaurants recently updated investors on its past quarter, outlining softer guest traffic, selective price increases, and tight cost control across Olive Garden, LongHorn Steakhouse, and other brands to protect industry-leading margins. Management’s emphasis on disciplined promotions and maintaining strong restaurant-level profitability, while still funding dividends, highlights Darden’s role as a relatively resilient, income-oriented casual dining operator. We’ll now examine how...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Intuit (INTU) Is Up 18.3% After Strong Q2, Higher Dividend And Anthropic AI Deal - Has The Bull Case Changed?

In late February 2026, Intuit Inc. reported higher revenue and earnings for its fiscal second quarter and first half, reaffirmed full‑year guidance, and approved a US$1.20 quarterly dividend per share, a 15% increase from the prior year period. At the same time, Intuit’s new multi‑year AI partnership with Anthropic aims to embed custom financial AI agents across mid‑market businesses and consumer experiences, potentially deepening usage of its TurboTax, QuickBooks, Credit Karma, and...
NasdaqCM:ALMU
NasdaqCM:ALMUSemiconductor

A Look At Aeluma (ALMU) Valuation After Positive Analyst Commentary Linked To Nvidia Optical Investments

Why Aeluma (ALMU) Is Back on Investors’ Radar Recent analyst commentary on Aeluma (ALMU), linking the company to favorable read-through from Nvidia’s optical investments, has sparked fresh interest following the stock’s short-term move of about 4.88%. See our latest analysis for Aeluma. That 4.88% short-term move around the recent analyst commentary sits against a share price of US$15.72 and a softer near term pattern, with the 1-day, 7-day and 90-day share price returns all in decline, even...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Alphabet (GOOGL) Valuation Check After Recent Share Price Pullback

Alphabet stock performance snapshot Alphabet (GOOGL) has seen mixed share price moves recently, with a 1 day return of around a 1% decline and a 7 day return of roughly a 2% decline. This sets the context for a deeper look at its fundamentals. See our latest analysis for Alphabet. While Alphabet’s 1 month share price return of around 11% decline and year to date share price return of about 5% decline point to cooling momentum in the short term, the 1 year total shareholder return of roughly...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

A Look At Zevra Therapeutics (ZVRA) Valuation After Recent Share Price Moves

Why Zevra Therapeutics (ZVRA) Is On Investors’ Radar Zevra Therapeutics (ZVRA) has been drawing attention after recent share price moves, with the stock down about 4% over the past month but up roughly 1% in the past 3 months. See our latest analysis for Zevra Therapeutics. At a latest share price of US$8.79, Zevra Therapeutics has seen short term share price pressure with a 7 day return of 3.3% and 30 day return of 4.0%. Its 1 year total shareholder return of 9.2% and 3 year total...
NYSE:VRT
NYSE:VRTElectrical

Does Vertiv’s New AI‑Driven Financing and BYOP&C Strategy Redefine the Bull Case For VRT?

In recent days, Vertiv Holdings Co completed an inaugural US$2.10 billion investment‑grade senior unsecured notes offering, refinanced its revolving credit facility, and expanded its AI-focused PowerBar Track busway range while rolling out a high-fidelity Digital Twin platform and a Bring Your Own Power & Cooling collaboration with Generate Capital for grid-constrained U.S. data centers. Together, these financing moves, AI-centric product launches, and infrastructure partnerships point to...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

Assessing PACCAR (PCAR) Valuation After Record 2025 Results And Moderate Buy Consensus

Why PACCAR’s latest results matter for investors PACCAR (PCAR) has released robust 2025 financial results, with record outcomes in its Parts and Financial Services segments, a material update that is likely front of mind for investors watching the stock’s recent performance. The company reported revenue of US$28.44b and net income of US$2.38b, while the share price has risen about 12% over the past 3 months yet still lagged its wider industrial sector peers. See our latest analysis for...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Amazon Weighs AWS Security Risks Against Expanding Global AI Data Centers

Drone strikes hit multiple Amazon Web Services data centers in the United Arab Emirates and Bahrain, causing damage and extended outages. Amazon.com, NasdaqGS:AMZN, is moving ahead with multibillion-dollar data center investments in Spain focused on AI and cloud capacity. The company has also entered a long-term AI collaboration with OpenAI that ties into its broader data center expansion plans. For investors watching Amazon.com, NasdaqGS:AMZN, the mix of physical risk and digital growth is...
NYSE:CLVT
NYSE:CLVTProfessional Services

Clarivate (CLVT) Valuation Check After Upgraded Earnings Estimates And Recurring Revenue And Debt Updates

Clarivate (CLVT) has been back on investors’ radar after a series of upward earnings estimate revisions, along with recent updates on recurring revenue, debt reduction efforts, and potential asset sales that together reframed the stock’s risk profile. See our latest analysis for Clarivate. The recent 22.75% 1 month share price return, together with a 7.92% gain over 7 days, suggests some near term momentum is returning after a 90 day share price decline of 28.45% and a 1 year total...
NasdaqGS:MNDY
NasdaqGS:MNDYSoftware

A Look At Monday.com (MNDY) Valuation After Robust ARR And Margin-Focused Quarterly Results

monday.com (MNDY) recently reported quarterly results that put its subscription engine in focus, with annual recurring revenue at US$1.34b, high gross margins, and quick payback on customer acquisition costs. See our latest analysis for monday.com. Despite the strong subscription metrics, monday.com’s recent share price performance has been weak. The 30-day share price return is 22.84% and the 90-day share price return is 49.99%. This has contributed to a 1-year total shareholder return of...
NYSE:RNGR
NYSE:RNGREnergy Services

Ranger Energy Services (RNGR) Margin Compression Tests Bullish Earnings Growth Narrative

Ranger Energy Services (RNGR) closed out FY 2025 with fourth quarter revenue of US$142.2 million and basic EPS of US$0.14, alongside net income excluding extra items of US$3.2 million, giving investors a clean snapshot of its latest run rate. The company has seen quarterly revenue move between US$128.9 million and US$153 million over the past six reported periods, while basic EPS has ranged from US$0.03 to US$0.39, setting a clear track record of how revenue and EPS have paired up through the...
NYSE:DNOW
NYSE:DNOWTrade Distributors

How Investors May Respond To DNOW (DNOW) Returning To Losses Amid ERP Troubles And Probes

In February 2026, DNOW Inc. reported fourth‑quarter 2025 sales of US$959 million, up from US$571 million a year earlier, but swung from net income of US$23 million to a net loss of US$147 million as continuing operations moved from earnings per share to losses per share. This shift back into loss‑making territory, despite higher full‑year sales and continued share repurchases, highlights how ERP implementation and integration issues are weighing heavily on profitability and have prompted...
NasdaqGS:ANAB
NasdaqGS:ANABBiotechs

The Bull Case For AnaptysBio (ANAB) Could Change Following Biopharma Spin-Off And Royalty Shift - Learn Why

AnaptysBio reported past fourth-quarter 2025 results showing net income of US$49.61 million versus a prior-year net loss, while announcing plans to spin off its biopharma operations into a separate public company, First Tracks Biotherapeutics, targeted for completion in the second quarter of 2026. The combination of sharply improved earnings, reduced full-year net loss to US$13.23 million, and expanding royalty revenue from GSK’s Jemperli underscores how AnaptysBio is reshaping itself around...
NYSE:SNOW
NYSE:SNOWIT

Snowflake Lawsuits And AI Partnerships Shape Valuation And Growth Debate

Snowflake (NYSE:SNOW) is facing a wave of securities class action lawsuits alleging it misled investors about how product efficiency efforts and pricing changes affected revenue. At the same time, the company has announced new AI partnerships with OpenAI and Anthropic, as well as expanded developer tooling through Cortex Code CLI. These developments highlight rising legal and reputational risk alongside efforts to broaden Snowflake's product ecosystem and integrations. Snowflake focuses on...
NYSE:MLR
NYSE:MLRMachinery

Miller Industries (MLR) Margin Compression Challenges Bullish Earnings Growth Narrative

Miller Industries (MLR) just wrapped up FY 2025 with fourth quarter revenue of US$171.9 million and basic EPS of US$0.30, alongside net income of US$3.4 million, setting the tone for how the full year is being read by the market. The company has seen quarterly revenue range from US$171.9 million to US$225.7 million over the last four reported quarters, with EPS moving between US$0.27 and US$0.74 as trailing twelve month totals reached US$790.3 million in revenue and EPS of US$2.01. With...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

CleanSpark (CLSK) Valuation Check After February 2026 Bitcoin Production Update

February production snapshot and why it matters CleanSpark (CLSK) released unaudited Bitcoin production figures for February 2026, reporting 568 Bitcoin mined, with peak single day output of 23.84 and an average daily level of 20.29. Because mining volume directly feeds potential revenue, these monthly data points give you a timely read on how CleanSpark's facilities are performing and how consistently they are converting power capacity into Bitcoin. See our latest analysis for...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Globalstar (GSAT) Valuation Check After Record 2025 Results And Confident 2026 Revenue Guidance

Globalstar (GSAT) is back in focus after reporting record 2025 revenue and sharply lower net losses, paired with 2026 revenue guidance of US$280 million to US$305 million that signals management confidence. See our latest analysis for Globalstar. At a share price of US$59.41, Globalstar has seen pressure recently with a 13.24% 90 day share price decline and a 7.16% year to date share price pullback. However, the 1 year total shareholder return of 164.99% and 3 year total shareholder return of...